DeMuth Peter
SEC insider (Form 3/4/5 filer). CIK 0001979163. Chief Scientific Officer at Elicio Therapeutics, Inc. (ELTX). 6 reported Form 4/5 transactions since Sep 2024; latest on Jul 16, 2026. Located in BOSTON, MA.
Companies DeMuth Peter has filed insider reports for
- Elicio Therapeutics, Inc. (ELTX): Officer, Chief Scientific Officer
DeMuth Peter
CIK: 0001979163
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Elicio Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jul 16, 2026ELTX
Elicio Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
52.8K shares- - Feb 2, 2026ELTX
Elicio Therapeutics, Inc.
AwardDirect20.8K shares- - Dec 9, 2025ELTX
Elicio Therapeutics, Inc.
ExerciseDirect362 shares at avg. $4.41$2K - Feb 3, 2025ELTX
Elicio Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
44.4K shares- - Dec 16, 2024ELTX
Elicio Therapeutics, Inc.
ExerciseDirect381 shares at avg. $4.41$2K - Sep 30, 2024ELTX
Elicio Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
29.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 16, 2026 | ELTX Elicio Therapeutics, Inc. | Award Stock Option (Right to Buy) | 52,832 | - | - | Direct |
| Feb 2, 2026 | ELTX Elicio Therapeutics, Inc. | Award | 20,800 | - | $0 | Direct |
| Dec 9, 2025 | ELTX Elicio Therapeutics, Inc. | Exercise | 362 | $4.41 | $1,596 | Direct |
| Feb 3, 2025 | ELTX Elicio Therapeutics, Inc. | Award Stock Option (Right to Buy) | 44,400 | - | - | Direct |
| Dec 16, 2024 | ELTX Elicio Therapeutics, Inc. | Exercise | 381 | $4.41 | $1,680 | Direct |
| Sep 30, 2024 | ELTX Elicio Therapeutics, Inc. | Award Stock Option (Right to Buy) | 29,800 | - | - | Direct |
1-6 of 6 transactions